Robert A Bradway is Chairman, CEO and President of AMGEN INC. Currently has a direct ownership of 413,499 shares of AMGN, which is worth approximately $115 Million. The most recent transaction as insider was on Jan 28, 2015, when has been sold 2,418 shares (Common Stock) at a price of $158.89 per share, resulting in proceeds of $384,196. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 413K
4.99% 3M change
38.22% 12M change
Total Value Held $115 Million

Robert A Bradway Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 28 2015
SELL
Payment of exercise price or tax liability
$384,196 $158.89 p/Share
2,418 Reduced 1.3%
183,243 Common Stock
May 12 2014
BUY
Open market or private purchase
$99,922 $111.77 p/Share
894 Added 0.48%
185,013 Common Stock
Apr 27 2014
SELL
Payment of exercise price or tax liability
$416,785 $111.41 p/Share
3,741 Reduced 1.99%
184,119 Common Stock
Apr 26 2014
SELL
Payment of exercise price or tax liability
$261,702 $111.41 p/Share
2,349 Reduced 1.23%
187,860 Common Stock
Apr 25 2014
SELL
Payment of exercise price or tax liability
$411,325 $113.72 p/Share
3,617 Reduced 1.87%
190,209 Common Stock

Also insider at

BA
BOEING CO Industrials
RAB

Robert A Bradway

Chairman, CEO and President
Thousand Oaks, CA

Track Institutional and Insider Activities on AMGN

Follow AMGEN INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

News

Receive news related to AMGEN INC

Track Activities on AMGN